ARE three-lens brief
Evidence-based stock research on ARE. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 23.7pp over 30 days. · Trading at 4% of its 52-week range — deep in the lower band.
- Trading at 4% of its 52-week range — deep in the lower band.
- Underperforming SPY by 23.7pp over 30 days.
- Analyst mean target $54.79 — 32% above current (14 analysts).
- Debt-to-equity of 66.5 — balance-sheet-heavy.
ARE closed at $41.48 (+0.22%) as of 2026-05-04. Market cap: $7.23B. Positives: analyst mean target $54.79 — 32% above current (14 analysts).. Concerns: trading at 4% of its 52-week range — deep in the lower band.; underperforming SPY by 23.7pp over 30 days.. Last quarter: Revenue $671.02M, net income $358.87M, free cash flow $1.41B.
Why three lenses on ARE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AREacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARE brief"></iframe>